| D008297 |
Male |
|
Males |
|
| D011239 |
Prednisolone |
A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. |
Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF |
|
| D011282 |
Pregnenediones |
Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures. |
Diketopregnenes,Dioxopregnenes |
|
| D002648 |
Child |
A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. |
Children |
|
| D005260 |
Female |
|
Females |
|
| D005938 |
Glucocorticoids |
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. |
Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D012189 |
Retrospective Studies |
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. |
Retrospective Study,Studies, Retrospective,Study, Retrospective |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|
| D058088 |
Sarcoglycanopathies |
Deficiencies or mutations in the genes for the SARCOGLYCAN COMPLEX subunits. A variety of phenotypes are associated with these mutations including a subgroup of autosomal recessive limb girdle muscular dystrophies, cardiomyopathies, and respiratory deficiency. |
Adhalinopathies,Adhalinopathy, Primary,Alpha-Sarcoglycanopathies,Alpha-Sarcoglycanopathy,Duchenne-Like Autosomal Recessive Muscular Dystrophy, Type 2,LGMD2D,Limb-Girdle Muscular Dystrophy, Type 2D,Muscular Dystrophy Limb-Girdle with Alpha-Sarcoglycan Deficiency,Muscular Dystrophy, Limb-Girdle, Type 2D,Sarcoglycanopathy,Adhalinopathies, Primary,Alpha Sarcoglycanopathies,Alpha Sarcoglycanopathy,Duchenne Like Autosomal Recessive Muscular Dystrophy, Type 2,Limb Girdle Muscular Dystrophy, Type 2D,Muscular Dystrophy Limb Girdle with Alpha Sarcoglycan Deficiency,Primary Adhalinopathies,Primary Adhalinopathy |
|
-transparent.png){kind=logo}
